France Biotech, in partnership with the Digital Therapeutics Alliance, is organizing the webinar “Exploring DTx Regulatory and Reimbursement Pathways in the United States” on March 25 from 1:30 PM to 2:30 PM.
Join us for this webinar series where we delve into the complexities of regulatory and reimbursement pathways for digital therapeutics in the United States, providing a comprehensive overview of those frameworks.
The speakers :
- Andy Molnar, Chief Executive Officer, Digital Therapeutics Alliance
- Stéphane Tholander, Vice President, Digital Health, France Biotech, and Co-founder, CEO, Agora Health